Skip to content

DIstraction Strategies for COlonoscopies (DISCO)

DIstraction Strategies for COlonoscopies (DISCO): Virtual Reality and Music Distraction versus Conscious Sedation during Colonoscopy: a Randomized Controlled Trial - Virtual reality and Music distraction versus conscious sedation during Colonoscopy: a randomized controlled trial’

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON58427
Enrollment
189
Registered
2025-11-14
Start date
2026-03-30
Completion date
Unknown
Last updated
2026-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colonoscopies Colonoscopies

Interventions

Two interventions will be studied in this trial: virtual reality and music distraction (instead of midazolam), with a (lowered) dose of fentanyl if needed.&nbsp

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: = 18 years of ageDiagnostic colonoscopy (bowel cancer screening program or surveillance) without a strict indication for conscious sedation or deep sedation

Exclusion criteria

Exclusion criteria: Interventional colonoscopy, or any other strict indication for conscious sedation or deep sedationHistory of psychiatric disorder (excluding depression)History of claustrophobiaHistory of epilepsyHistory of balance disordersSevere auditory impairment (impossibility to hear music without a hearing device) Limited proficiency of Dutch language and no interpreter

Design outcomes

Primary

MeasureTime frame
The effect of VR and MD on discomfort compared with standard of care SA.

Secondary

MeasureTime frame
To determine the need for escape medication when using VR or MD, to identify which groups benefit the most from VR or MD, to evaluate patient willingness, to evaluate the effect of VR and MD on anxiety, satisfaction, patient-perceived pain, (sedation-related) adverse events, vital signs, and procedure duration.  

Countries

Netherlands

Contacts

Public ContactC.S. Spijkerboer

Erasmus MC, Universitair Medisch Centrum Rotterdam

c.spijkerboer@erasmusmc.nl010 703 48 37

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: May 22, 2026